Influencia de la administración de corticoides sistémicos en el pronóstico de los pacientes con neumonía adquirida en la comunidad

Revista Clínica Española - Tập 212 - Trang 337-343 - 2012
J. Fernández-Herranz1, J. de Miguel-Díez2, A. del Castillo-Rueda3, J.M. Bellón-Cano4, R. Jiménez-García5, L.A. Álvarez-Sala-Walther3,6
1Servicio de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España
2Servicio de Neumología. Hospital General Universitario Gregorio Marañón. Madrid. España
3Servicio de Medicina Interna II. Hospital General Universitario Gregorio Marañón. Madrid. España
4Servicio de Medicina Preventiva. Hospital General Universitario Gregorio Marañón. Madrid. España
5Departamento de Medicina Preventiva, Universidad Rey Juan Carlos, Alcorcón, Madrid, España
6Miembro de la Red Temática de Investigación Cooperativa de Enfermedades Cardiovasculares (RECAVA RD006/014/0010)

Tài liệu tham khảo

Almirall, 2000, Epidemiology of community acquired pneumonia in adults: a population-based study, Eur Respir J, 15, 757, 10.1034/j.1399-3003.2000.15d21.x Murrie, 1991, Epidemiología de las neumonías adquiridas en la comunidad en el Área de Salud I de Navarra, Med Clin (Barc), 97, 50 Grupo de estudio de la neumonía adquirida en la comunidad, 2005, Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Normativas SEPAR, Arch Bronconeumol, 41, 272, 10.1157/13074594 Evans, 1938, Treatment of pneumonia with 2-(p-aminobenzenesulphonamide) pyrine, Lancet, 2, 14, 10.1016/S0140-6736(00)87996-9 Martínez-Olondrís, 2006, Conducta y tratamiento en la neumonía adquirida en la comunidad, JANO, 1595, 43 Ruiz-González, 1999, Is Streptococcus pneumoniae the leading cause of pneumonia of unknown aetiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia, Am J Med, 106, 385, 10.1016/S0002-9343(99)00050-9 Falguera, 2001, Non severe community-acquired pneumonia: a correlation between cause and severity or comorbidity, Arch Int Med, 161, 1866, 10.1001/archinte.161.15.1866 De Roux, 2004, Viral community-acquired pneumonia in nonimmunocompromised adults, Chest, 125, 1343, 10.1378/chest.125.4.1343 Houck, 2004, Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia, Arch Intern Med, 164, 637, 10.1001/archinte.164.6.637 Fernández, 2003, Molecular inflamatory responses measured in blood of patients with severe community-acquired pneumonia, Clin Diagn Lab Immunol, 10, 813, 10.1128/CDLI.10.5.813-820.2003 Toews, 2001, Cytokines and the lung, Eur Respir J Suppl, 34, 3S, 10.1183/09031936.01.00266001 Netea, 2003, Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing, Trends Immunol, 24, 254, 10.1016/S1471-4906(03)00079-6 Standiford, 2000, Cytokines as targets of immunotherapy in bacterial pneumonia, J Lab Clin Med, 135, 129, 10.1067/mlc.2000.103196 Moler, 2003, Streptococcous pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia, Intensive Care Med, 29, 808, 10.1007/s00134-003-1699-x Annane, 2006, Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome, Crit Care Med, 34, 22, 10.1097/01.CCM.0000194723.78632.62 Confalonieri, 2005, Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study, Am J Respir Crit Care, 171, 242, 10.1164/rccm.200406-808OC García-Vidal, 2007, Effects of systemic steroids in patients with severe community-acquired pneumonia, Eur Respir J, 30, 951, 10.1183/09031936.00027607 Gorman, 2007, Corticosteroid treatment of severe community-acquired pneumonia, Ann Pharmacother, 41, 1233, 10.1345/aph.1H660 Lamontagne, 2010, Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome and severe pneumonia: a meta-analysis of randomized controlled trials, J Crit Care, 25, 420, 10.1016/j.jcrc.2009.08.009 Snijders, 2010, Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial, Am J Respir Crit Care Med, 181, 975, 10.1164/rccm.200905-0808OC Salluh, 2011, Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study, J Crit Care, 26, 193, 10.1016/j.jcrc.2010.07.014 Fernández-Serrano, 2011, Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial, Crit Care, 15, R96, 10.1186/cc10103 Meijvis, 2011, Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomized, double-blind, placebo-controlled trial, Lancet, 377, 2023, 10.1016/S0140-6736(11)60607-7 Charlson, 1987, A new method of classifying prognosis comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Fine, 1997, A prediction rule to identify low-risk patients with community-acquired pneumonia, N Engl J Med, 336, 243, 10.1056/NEJM199701233360402